ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mr. Matthew - Cancer of the liver

Patient Basic Information Patient: Mr. Matthew (Matthew Lopez) Nationality: Kuwait Diagnosis: Liver Cancer Diagnostic Hospital: University of Ningbo Affiliated First Hospital Treatment Program: Blood stem cell transplant + chemotherapy Accommodation days: 98 days Treatment cost: approximately 685314 yuan Treatment effect: Stability of the disease Upon arrival at the First Hospital of the University of Ningbo, the International Medical Services team arranged for the first time multidisciplinary MDT sessions for patients, developed individualized pathways based on the patient's examination reports and physical condition, and provided translation, accompaniment and landing services throughout the treatment process. After 98 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard.

Treatment results The patient's final condition stabilized. When he was discharged, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track recovery through the remote follow-up system. 'Mr.

Matthew criticizes the case as a typical case of cross-border suspected serious clinical illness. The first hospital affiliated to the University of Ningbo relies on a multidisciplinary collaborative mechanism to develop a blood stem cell transplant + chemotherapy program for liver cancer, which reflects the comprehensive strength of Chinese hospitals in the field of suspected illness diagnosis and is a shorthand for the regulation of international visitor medical services.

科威特,肝癌,宁波大学附属第一医院,国际医疗,来华就医,中国医疗